JMCR Partners

Disclaimer This page is intended for qualified investors and no one should construe the contents of this page as legal, tax, investment, financial, or other advice. JMCR Partners is a family office that provide corporate and individual investment or/and financing solutions. JMCR family office was established in 2013, founded to manage the private assets for founder‘s family and close relations，including 隽华资本 JMCR Capital ® , 隽华国际 JMCR Partners ® and JMRE. Other past investments: • 1997 London Equity Market (personal dealings) • 2006 Index/Futures Trend strategy trading (around EURO 500m) • 2008 Viva Biotech, Founder/Angel Investor • 2013 Alibaba, PE/Pre-IPO • 2013 Launch quantitative strategy auto-trading funds (max size RMB 850m) • 2014 – 2017 Pre-Viva Ventures biotech fund RMB Fund (RMB 150m) • 2014 - 2017 Index systems/Stripe US VC/PE trades • Wanda Hongkong IPO • 2015 – 2017 Stepstone/Lightspeed/Amino/Y Combinate (Kickback) • Shunwei (Xiaomi)/CYZone/Huaxing US and RMB funds (total RMB 600m) • 2016 Viva Ventures biotech RMB Fund • 2018 Viva Ventures biotech USD Fund

Website

http://www.jmcrpartners.com

External link for JMCR Partners

Industry

Investment Management

Company size

11-50 employees

Headquarters

Hong Kong

Type

Partnership

Founded

2013

Specialties

Family Office, Wealth Management, Cashflow Management, Family Trusts, Equity Investment, Fund Investment, Quantitative Investing, and Biotech Invesments